Celularity Inc. (CELU) Financial Statements (2024 and earlier)

Company Profile

Business Address 170 PARK AVE
FLORHAM PARK, NJ 07932
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13,96637,240315917
Cash and cash equivalents13,96637,240315917
Receivables(1,789)(283)  
Inventory, net of allowances, customer advances and progress billings5,3089,549  
Inventory5,3089,549  
Prepaid expense 1,4267,0764592
Other current assets  2  
Other undisclosed current assets14,5915,516  
Total current assets:33,50259,1003591,009
Noncurrent Assets
Inventory, Noncurrent22,9492,721  
Operating lease, right-of-use asset13,060   
Property, plant and equipment75,65590,625  
Intangible assets, net (including goodwill)240,688246,491  
Goodwill119,694123,304  
Intangible assets, net (excluding goodwill)120,994123,187  
Asset, held-in-trust   291,797290,595
Restricted cash and investments14,83614,836  
Other noncurrent assets376355  
Other undisclosed noncurrent assets    2
Total noncurrent assets:367,564355,028291,797290,596
TOTAL ASSETS:401,066414,128292,156291,605
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:22,21220,9783,410210
Taxes payable  19
Accounts payable5,8109,317  
Accrued liabilities 16,40211,661  
Other undisclosed accounts payable and accrued liabilities   3,410191
Deferred revenue2,2732,196  
Debt37,603   
Other undisclosed current liabilities 3,051 19
Total current liabilities:62,08826,2253,410229
Noncurrent Liabilities
Liabilities, other than long-term debt30,5342,2161 
Deferred revenue2,2191,871  
Deferred income tax liabilities9101 
Other liabilities321335  
Operating lease, liability27,985   
Other undisclosed noncurrent liabilities109,543286,26974,61310,813
Total noncurrent liabilities:140,077288,48574,61310,813
Total liabilities:202,165314,71078,02311,042
Temporary equity, carrying amount   209,133275,564
Equity
Equity, attributable to parent, including:198,90199,4185,0005,000
Common stock15121 
Additional paid in capital844,373763,08748,3812,487
Accumulated other comprehensive income9   
Retained earnings (accumulated deficit)(645,496)(663,681)(43,383)2,512
Other undisclosed equity, attributable to parent   11
Total equity:198,90199,4185,0005,000
TOTAL LIABILITIES AND EQUITY:401,066414,128292,156291,605

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues17,97521,335  
Cost of revenue
(Cost of Goods and Services Sold)
(144,198)(159,693)  
Other undisclosed gross profit124,533150,040  
Gross profit:(1,690)11,682  
Operating expenses(150,187)(161,886)(4,220)(564)
Other undisclosed operating income126,27741,145  
Operating loss:(25,600)(109,059)(4,220)(564)
Nonoperating income (expense)39,8058,961(44,849)3,746
Investment income, nonoperating   1,7793,753
Other nonoperating income (expense)365(2,839)  
Interest and debt expense   (1,367) 
Income (loss) from continuing operations before equity method investments, income taxes:14,205(100,098)(50,436)3,181
Other undisclosed income from continuing operations before income taxes   1,367 
Income (loss) from continuing operations before income taxes:14,205(100,098)(49,069)3,181
Income tax expense (13)(20)(192)(668)
Other undisclosed income (loss) from continuing operations  48,980 
Income (loss) from continuing operations:14,192(100,118)(281)2,513
Income (loss) before gain (loss) on sale of properties:(100,118)(281)2,513
Net income (loss):14,192(100,118)(281)2,513
Net income attributable to noncontrolling interest   50,256 
Other undisclosed net loss attributable to parent   (99,236) 
Net income (loss) attributable to parent:14,192(100,118)(49,260)2,513
Preferred stock dividends and other adjustments    (2,731)
Net income (loss) available to common stockholders, diluted:14,192(100,118)(49,260)(218)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):14,192(100,118)(281)2,513
Comprehensive income (loss):14,192(100,118)(281)2,513
Other undisclosed comprehensive income, net of tax, attributable to parent9   
Comprehensive income (loss), net of tax, attributable to parent:14,201(100,118)(281)2,513

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: